logo

[breadcrumb_custom]

Recursion Pharmaceuticals Inc (RXRX) Stock: A Year of Highs and Lows in the Market

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Recursion Pharmaceuticals Inc’s current trading price is -47.32% away from its 52-week high, while its distance from the 52-week low is 94.32%. The stock’s price range for this period has been between $4.54 and $16.75 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.01 million for the day, a number notably lower than the average daily volume of 7.17 million over the last three months.

Recursion Pharmaceuticals Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $16.75 on 07/19/23, while the lowest price for the same period was registered at $4.54 on 05/02/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly decline of -10.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.90B.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 9.86, with a change in price of +3.32. Similarly, Recursion Pharmaceuticals Inc recorded 6,352,024 in trading volume during the last 100 days, posting a change of +59.95%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.10.

RXRX Stock Stochastic Average

Recursion Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 2.48%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 4.59%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 2.17% and 1.48%, respectively.

RXRX Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -10.53% this year. Over the last six months, there has been a weaker performance of 15.32%. The price of RXRX leaped by -31.13% during the last 30 days period. For the last 5-days stocks have slided -16.22%.

On Key

Related Posts